Cultures have revealed a type of bacteria with a really, really long name: Verona Integron‐mediated Metallo‐β‐lactamase (VIM)‐ and Guiana‐Extended Spectrum‐β‐Lactamase (GES ...
Pfizer's novel combination antibiotic Emblaveo (aztreonam-avibactam) will be an option for infections that have limited ...
A large retrospective cohort pharmacoepidemiologic study found that despite approval by the U.S. Food and Drug Administration ...
More information: Abstract: In vitro activity of antimicrobial peptide from African catfish against the Extended-Spectrum ...
In space conditions, the highly pathogenic bacteria Enterobacter bugandensis becomes even more dangerous due to its smart ...
Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO® ...
The European Commission (EC) has granted marketing authorisation for Pfizer’s EMBLAVEO (aztreonam-avibactam), aimed at ...
American researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as ...
Hospitalization rates rose for all age-groups in 2021 and 2022 compared to the prepandemic period, with children aged 2 to 5 ...
Cefdinir is stable in the presence of some, but not all, β-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins are susceptible to cefdinir. Treatment ...
Among children treated with an oral agent, the recurrence rate was 16/42 (38.1%) following penicillin or amoxicillin and 10/36 (27.8%) following a beta-lactamase resistant agent (adjusted odds ...